End-of-study B-Well data show 91% of patients with chronic hepatitis B who achieved functional cure with bepirovirsen maintained it through Week 96.
|Articles|February 20, 2023
Rheumatoid Arthritis Quiz: Opioids and RA
Author(s)Ingrid Torjesen
How much do you know about opioid usage in patients with rheumatoid arthritis? Test your knowledge with this quiz.
Advertisement
Is the following statement true or false?
A Cochrane review concluded that weak opioids may be effective analgesics for some patients with rheumatoid arthritis (RA) could be used as an alternate bridging therapy to glucocorticoids for up to 3 months until the benefits of DMARDs are realised.
Advertisement
Related to this article
With LDL-C target-guided titration, starting statin plus ezetimibe vs a statin alone yielded similar 3-year events in ASCVD.
Stopping statins was noninferior at 2 years in adults 70 and older without CVD, but events were higher over full follow-up (12.7% vs 9.2%).
Post hoc phase 2 data show survodutide improved MASH and fibrosis endpoints across all weight loss categories, including patients losing less than 5%.
Asundexian lowered ischemic stroke without more major bleeding across low, intermediate, and high Framingham risk groups (all P interaction > .25).
Adding spironolactone lowered 3-month home SBP by 7.7 mm Hg vs standard care in 160 stroke survivors with uncontrolled hypertension.
A systolic target below 120 mm Hg lowered major cardiovascular events vs below 140 mm Hg in 4368 patients with prior ischemic stroke or TIA.
Chronic hypertension in pregnancy was tied to 30% higher odds of critical congenital heart disease in a study of 44 million US births.
Advertisement
Advertisement
Trending on HCPLive
1
Lp(a) HORIZON Shows Pelacarsen Lowers Lp(a) 78% But Not Cardiovascular Events
2
Cannabis Use Tied to Higher Odds of Stroke, Cardiovascular Disease
3
ZEUS: Ziltivekimab Fails to Reduce Cardiovascular Events in ASCVD and CKD
4
AHA 2026: Intensive Blood Pressure Control Reduces Events After Ischemic Stroke
5